Abbott India Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

His tenure will be for a period of five years, effective from 14 June 2025, to 13 June 2030.

The appointment is expected to provide continued strategic leadership and drive growth initiatives for the company in the coming years.

Abbott India is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.

Abbott India?s standalone net profit climbed 15.79% to Rs 415.27 crore on 7.62% increase in revenue from operations to Rs 1,757.15 crore in Q2 FY26 over Q2 FY25.

Shares of Abbott India shed 0.63% to currently trade at Rs 29,536.05 on the BSE.

Powered by Capital Market - Live News

Abbott India has received approval from the Central Government under Section 196 of the Companies Act, 2013 for the appointment of Kartik Rajendran (DIN: 09527717) as the Managing Director of the Company, for a period of 5 (five) years, with effect from 14 June 2025 to 13 June 2030.

Powered by Capital Market - Live News

Net profit of Abbott India rose 15.80% to Rs 415.27 crore in the quarter ended September 2025 as against Rs 358.61 crore during the previous quarter ended September 2024. Sales rose 7.62% to Rs 1757.15 crore in the quarter ended September 2025 as against Rs 1632.67 crore during the previous quarter ended September 2024.

Powered by Capital Market - Live News

Profit before tax (PBT) stood at Rs 545.93 crore in Q2 FY26, up 13.87% year on year (YoY).

Total expenses increased 5.55% to Rs 1,281.17 crore in Q2 FY26 as against Rs 1,213.72 crore posted in same quarter last year. The cost of materials consumed stood at Rs 162.59 crore (down 5.50% YoY), employee benefit expense was at Rs 158.98 crore (up 7.85% YoY) and finance cost was at Rs 7.55 crore (up 202% YoY) during the period under review.

Abbott India is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.

Shares of Abbott India rose 0.77% to settle at Rs 29,593.20 on the BSE.

Powered by Capital Market - Live News